依达拉奉治疗急性脑出血的临床疗效观察

Clinical Observation of Edaravone in Treatment of Acute Cerebral Hemorrhage

目的观察依达拉奉治疗脑出血的临床疗效.方法将64例脑出血患者随机分为对照组32例采用常规治疗和治疗组32例在常规治疗的基础上加用依达拉奉30 mg静滴,bid,共14 d.结果治疗组在1个月后临床疗效、神经功能缺损评分改善明显优于对照组(P<0.05).结论依达拉奉治疗脑出血安全有效,值得临床推广应用.

Objective To observe the clinical curative efficacy of edaravone in treatment of acute cerebral hemorrhage.Methods Sixty four cases were randomly divided into treatment group(n=32)and control group(n=32).Patients in the control group were given routine treatment of acute cerebral hemorrhage.Patients in the treatment group were treated with edaravone in addition to the routine treatment,bid,a total of 14d.Results Clinical efficacy of the treatment group after 1 month,neural function defect score improvement was significantly better than the control group(P<0.05).Conclusion Edaravone in treatment of cerebral hemorrhage is safe and effective,and is worth generalizing in clinical application.